Zydus Lifesciences Ltd., formerly known as Cadila Healthcare Ltd., is an Indian multinational pharmaceutical company headquartered in Ahmedabad. It primarily engages in the manufacture of generic drugs. Zydus Lifesciences aims to make a meaningful difference in serving patients and communities through its path-breaking discoveries and commitment to care.
DETAILS:
Particulars | Details |
---|---|
Buyback Type: | Tender Offer |
Buyback Price per share: | ₹ 1,005/- |
Buyback Offer Amount | ₹ 600 Cr. |
No. of shares for Buyback: | 59,70,149 |
Face value of Share: | ₹ 10/- |
Date of Board Meeting: | 09/02/2024 |
Date of Public Annoucement: | 09/02/2024 |
Record Date: | 23/02/2024 |
Tags:
Buyback